- Clinical Trials
- April 2024
- 60 Pages
Global
From €1930EUR$2,000USD£1,656GBP
Fampridine is a drug used to treat multiple sclerosis (MS). It is a potassium channel blocker that helps improve nerve conduction in people with MS. It is used to improve walking ability and reduce fatigue in people with MS. Fampridine is available in both oral and intravenous forms. It is typically used as a second-line treatment for MS, after other treatments have failed.
Fampridine is a relatively new drug, and the market for it is still developing. It is primarily used in the United States and Europe, but is also available in other countries. The drug is typically prescribed by neurologists and other specialists who treat MS.
The market for Fampridine is expected to grow in the coming years, as more people are diagnosed with MS and more treatments become available.
Some companies in the Fampridine market include Acorda Therapeutics, Biogen, Merck, Novartis, and Sanofi. Show Less Read more